Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Mistras Group
MG
$484M
| $9.01M | 0.01% |
549,640
+102,400
| +23% | +$1.57M |
|
1452
RBC Bearings
RBC
$17.4B
| $9.01M | 0.01% |
+54,300
| New | +$8.78M |
|
1453
SM Energy
SM
$7.8B
| $9.01M | 0.01% |
929,400
-92,000
| -9% | -$938K |
|
1454
Titan International
TWI
$466M
| $8.97M | 0.01% |
3,323,700
+43,400
| +1% | +$143K |
|
1455
First Trust Preferred Securities and Income ETF
FPE
$6.32B
| $8.95M | 0.01% |
453,771
-70,029
| -13% | -$1.37M |
|
1456
Enterprise Products Partners
EPD
$82.3B
| $8.95M | 0.01% |
313,191
-1,690,558
| -84% | -$49.2M |
|
1457
Check Point Software Technologies
CHKP
$13B
| $8.94M | 0.01% |
81,600
+21,592
| +36% | +$2.41M |
|
|
MRLN
1458
DELISTED
Marlin Business Services Corp
MRLN
| $8.91M | 0.01% |
353,600
+19,200
| +6% | +$447K |
|
|
AXIA
1459
AXIA Energia
AXIA
$23.9B
| $8.89M | 0.01% |
1,171,787
+230,973
| +25% | +$1.89M |
|
1460
InterContinental Hotels
IHG
$23.9B
| $8.89M | 0.01% |
142,664
+57,383
| +67% | +$3.75M |
|
1461
Green Plains
GPRE
$1.18B
| $8.88M | 0.01% |
838,000
-123,643
| -13% | -$1.18M |
|
|
IBKC
1462
DELISTED
IBERIABANK Corp
IBKC
| $8.87M | 0.01% |
117,448
+80,200
| +215% | +$5.91M |
|
1463
Genpact
G
$5.96B
| $8.87M | 0.01% |
228,900
-43,900
| -16% | -$1.74M |
|
1464
Donegal Group Class A
DGICA
$731M
| $8.83M | 0.01% |
602,019
+71,810
| +14% | +$1.04M |
|
1465
Hecla Mining
HL
$9.47B
| $8.8M | 0.01% |
4,999,602
+3,755,312
| +302% | +$6.77M |
|
|
VNET
1466
VNET Group
VNET
$2.04B
| $8.8M | 0.01% |
1,154,767
-35,800
| -3% | -$275K |
|
|
CCXI
1467
DELISTED
ChemoCentryx, Inc.
CCXI
| $8.79M | 0.01% |
1,295,979
-169,402
| -12% | -$1.27M |
|
1468
iRadimed
IRMD
$1.16B
| $8.77M | 0.01% |
417,100
+53,700
| +15% | +$1.1M |
|
|
LUNA
1469
DELISTED
Luna Innovations Incorporated
LUNA
| $8.76M | 0.01% |
1,512,507
+222,057
| +17% | +$1.23M |
|
1470
Rocky Brands
RCKY
$366M
| $8.76M | 0.01% |
263,492
+72,192
| +38% | +$2.15M |
|
1471
Columbus McKinnon
CMCO
$553M
| $8.75M | 0.01% |
240,300
+34,715
| +17% | +$1.29M |
|
|
PRGX
1472
DELISTED
PRGX Global, Inc.
PRGX
| $8.72M | 0.01% |
1,693,410
-19,500
| -1% | -$113K |
|
1473
Prosperity Bancshares
PB
$8.97B
| $8.7M | 0.01% |
123,232
+47,644
| +63% | +$3.2M |
|
1474
Synaptics
SYNA
$4.19B
| $8.69M | 0.01% |
+217,627
| New | +$7.35M |
|
1475
Luxfer Holdings
LXFR
$456M
| $8.69M | 0.01% |
557,700
-255,700
| -31% | -$4.69M |
|
Similar funds
Renaissance Technologies's Q3 2019 Portfolio in Review
As of Q3 2019, Renaissance Technologies held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Renaissance Technologies's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Renaissance Technologies added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Renaissance Technologies's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Renaissance Technologies fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Renaissance Technologies's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Renaissance Technologies opened 406 new positions and closed 522 in Q3 2019.
- Renaissance Technologies's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.